Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A comparison between intraperitoneal and extraperitoneal left ventricular assist system placement

A Wasler1, W E Springer, B Radovancevic

  • 1Department of Cardiovascular Surgery, Texas Heart Institute, St. Luke's Episcopal Hospital, Houston, USA.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|September 1, 1996
PubMed
Summary

Intraperitoneal (IP) placement of the HeartMate left ventricular assist system (LVAS) may reduce device-related infections compared to extraperitoneal (EP) placement. While bleeding rates were similar, IP placement showed a trend towards fewer device-related infections in heart failure patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Posttraumatic growth in individuals with amputations.

Disability and health journal·2015
Same author

Low incidence of coronary angiography in the evaluation process of the potential heart donor.

Transplantation proceedings·2014
Same author

Case of Paracoccus yeei infection documented in a transplanted heart.

Transplant infectious disease : an official journal of the Transplantation Society·2010
Same author

Testosterone-related shortening of QTc interval in women with polycystic ovary syndrome.

Journal of endocrinological investigation·2008
Same author

Lessons learned with noninvasive cardiac monitoring for acute rejection.

Transplantation proceedings·2007
Same author

Heart retransplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007

Area of Science:

  • Cardiovascular Surgery
  • Medical Devices
  • Heart Failure Management

Background:

  • The HeartMate left ventricular assist system (LVAS) is crucial for bridging heart transplants and managing chronic heart failure.
  • Minimizing complications during long-term LVAS use depends on surgical techniques and anatomic placement.
  • Device-related bleeding, infection, and intra-abdominal issues are serious adverse events linked to LVAS positioning.

Purpose of the Study:

  • To retrospectively analyze clinical data from 48 HeartMate patients.
  • To compare serious complication rates between intraperitoneal (IP) and extraperitoneal (EP) LVAS placements.
  • To identify optimal LVAS placement strategies for reducing adverse events.

Main Methods:

  • Retrospective analysis of clinical data from 48 patients with HeartMate LVAS support.

Related Experiment Videos

  • Categorization of patients into intraperitoneal (IP) and extraperitoneal (EP) placement groups (37 IP, 11 EP).
  • Comparison of postoperative bleeding, device-related bleeding, infection rates, and transplantation rates between the two groups.

    • Main Results:

    • Postoperative bleeding requiring reoperation occurred in 57% (IP) and 64% (EP) of patients; device-related bleeding was 8% (IP) vs. 29% (EP), neither statistically significant.
    • Overall infection rates were similar (45.7% IP vs. 46.2% EP), but device-related infections were significantly higher in the EP group (46% vs. 14% IP, p=0.025).
    • Intra-abdominal complications were minimal, and transplantation rates were higher in the EP group (78%) compared to the IP group (64%).

    Conclusions:

    • Intraperitoneal LVAS placement may provide enhanced protection against device-related infections.
    • While not statistically significant, IP placement showed a lower rate of device-related bleeding.
    • Further research into LVAS placement strategies is warranted to optimize patient outcomes and minimize complications.